ECHO Trademark

Trademark Overview

On Monday, December 4, 2023, a trademark application was filed for ECHO with the United States Patent and Trademark Office. The USPTO has given the ECHO trademark a serial number of 98298155. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Thursday, January 15, 2026. This trademark is owned by Ncardia B.V.. The ECHO trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

custom manufacture of therapeutic iPSC-based cells, iPSC-based cell therapies and iPSC-based allogeneic edited cell therapies for others; custom manufacture of iPSC-based allogeneic cell therapies

scientific research, design and technological development services in the fields of scientific iPSC-based cell cultures, iPSC-based cell therapies, and iPSC-based gene-edited cell therapy; scientific research, design and development of manufacturing processes in the fields of cell culture, cell therapy, and gene edited cell therapy, for others; scientific consultation services in the field of biotechnology, specifically in relation to iPSC-based cell culture, iPSC-based cell therapy, or iPSC-based gene edited cell therapy manufacturing
echo

General Information

Serial Number98298155
Word MarkECHO
Filing DateMonday, December 4, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateThursday, January 15, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements

Goods and Servicescustom manufacture of therapeutic iPSC-based cells, iPSC-based cell therapies and iPSC-based allogeneic edited cell therapies for others; custom manufacture of iPSC-based allogeneic cell therapies
Goods and Servicesscientific research, design and technological development services in the fields of scientific iPSC-based cell cultures, iPSC-based cell therapies, and iPSC-based gene-edited cell therapy; scientific research, design and development of manufacturing processes in the fields of cell culture, cell therapy, and gene edited cell therapy, for others; scientific consultation services in the field of biotechnology, specifically in relation to iPSC-based cell culture, iPSC-based cell therapy, or iPSC-based gene edited cell therapy manufacturing

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, December 4, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 4, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCELYNTRA THERAPEUTICS SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressMONT-SAINT-GUIBERT 1435
BE
Party NameCELYNTRA THERAPEUTICS SA
Party Type11 - New Owner Before Publication
Legal Entity Type33 - NOT AVAILABLE
AddressMONT-SAINT-GUIBERT 1435
BE
Party NameNcardia B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLEIDEN 2333BD
NL

Trademark Events

Event DateEvent Description
Monday, December 4, 2023NEW APPLICATION ENTERED
Wednesday, February 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 19, 2024ASSIGNED TO EXAMINER
Saturday, March 23, 2024NON-FINAL ACTION WRITTEN
Saturday, March 23, 2024NON-FINAL ACTION E-MAILED
Saturday, March 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 10, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 10, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 10, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, August 4, 2024FINAL REFUSAL WRITTEN
Sunday, August 4, 2024FINAL REFUSAL E-MAILED
Sunday, August 4, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 7, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 7, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, October 25, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, October 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 2, 2025EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, May 30, 2025OPPOSITION INSTITUTED NO. 999999
Sunday, June 1, 2025EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, January 14, 2026OPPOSITION DISMISSED NO. 999999
Wednesday, January 14, 2026OPPOSITION TERMINATED NO. 999999
Wednesday, January 14, 2026TTAB RELEASE CASE TO TRADEMARKS

Related Keywords

echo cell based ipsc therapy therapies edited scientific gene fields services